METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat prostate cancer: experimental drug targets resistant tumors
Disease control Recruiting nowThis study tests an experimental drug called pasritamig, which helps the body's immune cells attack prostate cancer cells. It is for people with metastatic castration-resistant prostate cancer, meaning the cancer has spread and stopped responding to hormone therapy. About 663 par…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New hope for advanced prostate cancer: experimental combo enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug (JNJ-78278343) combined with other treatments for men whose prostate cancer has spread and no longer responds to hormone therapy. The goal is to find the safest and most effective dose and to monitor side effects. About 300 participants wil…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 08:52 UTC